While vaccines remain the best strategy to prevent COVID-19, mAbs could potentially benefit certain vulnerable populations before or after exposure to SARS-CoV-2, such as the unvaccinated or recently vaccinated high-risk patients.
MIT License
1
stars
4
forks
source link
feat: extract total number of people in high risk group #53
gitpod-io[bot]
commented
2 years ago 
Reviewers' comment 2.3.